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ABSTRACT
Epilepsy is one of the common neurological disorders that are seen worldwide. It can also affect a person’s social, mental, and physiological well-being 
and thus restricts and disables the common living of man. Depression as such has been well reported in patients with epilepsy, and also depression 
itself remains a factor that can lead to the development of epilepsy. Increased rates of suicidal tendencies are also associated with depression both 
in men and women. Depression is further extended in affecting the quality of life in epileptic patients. Depressive rates are found to have a higher 
value in epileptic patients when compared with the normal population. This article aims to produce a comprehensive review of the epidemiological 
considerations, clinical findings and management strategies for depression associated with epilepsy.
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INTRODUCTION
Epilepsy is one of the common neurological disorders that is seen 
worldwide [1]. Epilepsy, anxiety, and depression are related disorders. 
It is, therefore, not a surprising issue that patients exhibit all of these 
together. About 55% lifetime prevalence for depression was found in 
epileptic patients which was tend to be high and that with temporal lobe 
epilepsy is estimated as 35% [2]. Depression directly increases seizure 
frequency through sleep deprivation. Failure to realize the patients with 
depression or a delay or inadequate treatment can lead them to suicide. 
Depression also reduces the compliance of the patient to antiepileptic 
medication [3]. People with epilepsy (PWE) will experience depression 
at a higher rate, mainly two-three fold when compared to a general 
population [4]. Depression is the psychiatric comorbidity which is 
seen more frequently in patients with epilepsy [2]. PWE and comorbid 
depression have reported lower quality of life [2]. Therefore, a study 
to determine the impact of depression and its related symptoms in 
epileptic patients is warranted to improve their quality of life.
The aim of this review is to bring into light the available evidence 
about the certain aspects of the comorbidity of depression in epileptic 
patients as the two are closely associated with one another.
DEPRESSION AND EPILEPSY- TWO WAY STREET
Depression is the psychiatric comorbidity which is seen more frequently 
in PWE [5,6]. The association between both has been well established in 
various studies. Studies have noted that rate of depression tends to be 
high among epileptic patients than in a normal population or in subjects 
with other chronic diseases such as diabetes and hypertension [7]. 
For a considerable time period, depression was thought to be a chain 
reaction of epilepsy [7]. Demonstration of depressive disorders in 
patients with epilepsy have been multifaceted, with many psychological 
and neurobiological interactions, which also includes various clinical 
characteristics of epilepsy and possible neurochemical mechanisms 
[8,9]. Not only epilepsy can cause depression, but also depressive 
episodes showed increased the risks of developing seizures.
Colin et al., in this study, have discussed about the relevance of 
a bi-directional relationship that exists between depression and 
epilepsy. In this observational study of a population-based primary 
cohort identified. We identified 10,595,709 patients in The Health 
Improvement Network of whom 229,164 (2.2%) developed depression 
and 97,177 (0.9%) developed epilepsy. Significantly more patients 
from the population with depression (144,373 [63%] were women and 
84,791 [37%] were men; p<0.001) or epilepsy (54,419 [56%] were 
women and 42,758 [44%] were men; p<0.001) were female. It was 
also observed that incident epilepsy was related to an increased risk 
of developing depression (hazard ratio [HR], 2.04 [95% CI, 1.97-2.09]; 
p<0.001), and incident depression was associated with an increased 
risk of developing epilepsy (HR, 2.55 [95% CI, 2.49-2.60]; p<0.001) 
there was an incremental hazard according to depression treatment 
type and lowest risk was seen for those receiving counseling alone 
(HR, 1.84 [95% CI, 1.30-2.59]; p<0.001), an intermediate risk was 
seen for those receiving antidepressants alone (HR, 3.43 [95% CI, 
3.37-3.47]; p<0.001), and the highest risk was seen for those receiving 
both (HR, 9.85 [95% CI, 5.74-16.90]; p<0.001). He concluded that 
treated depression is associated with worse epilepsy outcomes thereby 
suggesting that it may be a surrogate for more severe depression and 
that severity of both depression and epilepsy is inter-related [10].
Attarian et al., in this study, have concluded that PWE have a 
predominance of depression than in normal population. Seizure 
free patients for a period of more than 6 months were considered 
not intractable. Of the total number of patients, 36% were neither 
intractable nor depressed. 43% was found to have intractable epilepsy 
but were not depressed. The results indicate that 10% had both 
intractable epilepsy and depression and 11% did not have intractable 
epilepsy but was found depressed [11].
A study by Gilliam et al. have concluded by saying that presence of 
depression is considered as a strongest predictor of health status of the 
patient [12].
All these studies reveal that there is a considerable relation between 
epilepsy and depression and it also worsens with the increase in the 
severity of epilepsy.
PSYCHOLOGICAL DISORDERS IN PATIENTS WITH EPILEPSY
Acute psychological disorders (APDs) are a most prevailing problem 
faced by epileptic patients, with an approximate estimate varying from 
2% to 16% as per the studied population [13]. Epileptic patients are 
very often confronted with mood disorders.
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Cockerell et al. conducted a study using an ongoing prospective 
surveillance system to determine the epileptic patients who developed 
APDs. 64 cases were determined. Location-related epilepsy was 
found to be predominant in the subjects included. 31 (48%) patients 
presented with APD due to ictal or post-ictal activity [13].
Mula et al. conducted a study on 143 out-patients, only adults, with 
epilepsy comprising 83 females and 60 males. Of the total, 17 patients 
(11.9%) were diagnosed to have bipolar disorder (BD) according to 
DSM-IV criteria; moreover, 21 patients (14.7%) were screened positively 
for bipolar symptoms (BS) using mood disorder questionnaire (MDQ). 
This showed that a higher occurrence of psychological disorders is 
present in PWE [14].
A multistage random cluster sampling was done by Richard et al., 
against 1403 subjects of age 8-12 years old including all the households 
in two rural areas in Calicut district in Kerala. The screening interview 
was administered to the caretaker of every subject which included 
demographic data, expectation of parents’ on children for participation 
in house works using a Malayalam version of Rutter’s A2 questionnaire 
as a measure of child psychiatric disturbance and items indicating the 
social impact of child’s disorder (adapted from the Ontario child health 
study). A poverty score was also designed from 8 equally-weighted 
items. 95% of the teachers in the sample completed Malayalam version 
of Rutter’s B2 child behavior questionnaire [15,16]. 26 children were 
in accordance to the definition of epilepsy. The guardians/parents of 
these epileptic children had only lower expectations, and only 50% of 
them expect to continue education for their children beyond 16 years 
compared with 77% of controls (χ2=6.83, p=0.009). School attendance 
was also found to be significantly lower in these children. Children 
with epilepsy were predominantly more disturbed than the normal 
population on the Rutter (parent) questionnaire. Thus, evidence 
was obtained that epilepsy severely interferes with the psychiatric 
well-being, cognitive and academic performance of children in the 
South Indian population and also their personal life [15].
Kogeorgos et al. assessed the presence of psychiatric comorbidity 
in 66 chronic epilepsy out-patients with the help of two self-rating 
psychopathology questionnaires which had established reliability, 
consistency and validity. His study showed that around half (45.5%) 
of the population was psychiatrically ill. When compared with a 
population of chronic neurological out-patients, patients with epilepsy 
showed higher rates of psychiatric comorbidities. Most predominant 
conditions were depression, anxiety, and hysteria [17].
Ettinger et al., in this study using a validated instrument, the MDQ 
which in conjugation with questions about prevailing health issues, 
was used against 127,800 adult subjects in the US. On comparison of 
patients diagnosed with epilepsy and those with migraine, asthma, and 
diabetes mellitus it was evident that BS presented high, approximately 
1.6-2.2 times, in epileptic population than in patients with migraine, 
diabetes, and asthma [18].
Kathryn et al. conducted a cross-sectional, case–control survey among 
the children in Tanzania between the ages ranging from 6 to 14 years 
with active epilepsy. Comorbidities were assessed and compared 
with control groups. Comorbidities were very common among 
cases (95/112, 85%) and (62/112, 55%) cases showed multiple 
comorbidities. Comorbidities consisted of cognitive impairment, 
behavior disorder, motor difficulties, burns and other previous injuries 
and these complications were found to be common in these cases 
than in controls (odds ratio 14.8, 95% CI 7.6-28.6, p<0.001). Thus, he 
concluded that high level of comorbidity was seen in children’s with 
epilepsy in Sub-Saharan Africa [19].
Psychological disorders hence are found mostly in epileptic patients. 
These conditions are often left unrecognized. Other than depression, 
anxiety psychosis is also found to be predominant in epileptic patients. 
Occurrence of such comorbidities needs to be assessed carefully in 
order for providing proper care. Other studies related to Psychological 
disorders in PWE are listed in Table 1.
PREVELANCE OF DEPRESSION IN EPILEPSY
Most of the studies have determined the predominance of psychiatric 
disorders in epilepsy which are characterized by considerable 
heterogeneity which is due to the differences in settings of the 
population and the study type underwent [20].
Jose et al., in this study to estimate the prevalence of mental disorders 
in those with epilepsy with the means of Canadian Community Health 
Survey 1.2, to identify numerous aspects of mental health in persons 
with epilepsy. The prevalence of epilepsy was seen as 0.6%. Prevalence 
of mental health disorders in those with epilepsy was also determined 
and was found to be 23.5 for 12 month period and 35.5 when checked 
for lifetime [21].
Occurrence of depression in epileptic patients and the associated factors 
were determined by Samart et al. in a cross-sectional study where 
110 patients were enrolled overall, and among them, 60 patients only 
conformed to the inclusion criteria. Patients were screened using the 
Thai geriatric depressive scale. Prevalence of depression was obtained 
overall as 38.3%. Depression was diagnosed as 36.8% in males and 
40.9% in females. No significant difference (p=0.75) was seen when 
male and female population was compared. Age group also showed 
no significant difference (p=0.77). Other variables such as duration of 
seizures, type of seizures and number of anti-epileptic drugs (AEDs) 
showed no significant difference among epileptic patients and thus 
concluded that they are not the risk factors associated with depression 
[22]. On the contrary, Ting Zhao et al. depicted that the strongest 
predictors of depression were the type of seizure (odds ratio = 3.773, 
p=0.049, β=1.328). Weaker predictors included the seizure worry 
scores (OR=0.947, p=0.030, β=−0.54), social function scores (OR=0.947, 
p=0.000, β=−0.10) and complex partial seizure score (OR=0.112, 
p=0.002, β=−2.187) [23]. Thus, two opinions have been raised when the 
factors that cause depression in epileptic patients were checked into.
Mohammadi et al. determined the lifetime prevalence of self-reported 
and relative informants-reported epilepsy among Iranian adult of 
age 18 years and above using a cross-sectional epidemiological study 
and identified the possible relation between epilepsy and lifetime 
psychiatric disorders. 25,180 individual were selected from all the 
Iranian households and interviewed face to face using epilepsy 
questionnaire. The response rate was observed as 90%. The prevalence 
rate of epilepsy was identified as 1.8%. Epilepsy was observed to be 
more predominant in females, unemployed people and people with 
higher educational status. Factors such as age group, marital status, and 
residential areas were not associated with epilepsy. The predominant 
psychiatric comorbidity which was seen in subjects with epilepsy were 
major depressive disorder and obsessive-compulsive disorder and the 
rate of lifetime suicidal attempt was observed to be as 8.1% [24].
A cross-sectional observational study where patients were evaluated 
by mini international neuropsychiatric interview by Sajjadur 
et al. conducted to see their psychiatric comorbidities and the 
sociodemographic and clinical factors. Psychiatric comorbidity was 
seen in 50% of the subjects with epilepsy. Depression 18%, psychosis 
14%, and anxiety disorders 11% were the other most commonly 
found psychiatric comorbidities. Presence of partial seizures, frequent 
seizures, long duration of epilepsy, and poor compliance to AED are 
other major factors that were significantly associated with the presence 
of psychiatric comorbidity in persons with epilepsy [25].
Prevalence of depression in epilepsy has found its stand itself to be very 
high when it is compared with the normal population in the society. 
The severity of depression alters accordingly with the type of seizure 
undergone by the patient, age and type of therapy undertaken by the 
patient. On concluding, depression is a factor that requires proper 
medical care mainly in epileptic patients.
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FREQUENCY OF DEPRESSION IN EPILEPSY
Depression is the considered to be the most expected psychiatric 
morbidity among people with epilepsy and also have an adverse 
effect on their quality of life [34]. It has also been noted that 30-50% 
of epileptic patients reported with clinical depression [35,36]. Among 
50 million PWE worldwide, 15-60% are also likely to experience any 
forms of depression or anxiety disorders, and 80% of those people 
are from a low economic status where these comorbidities remain 
concealed and thus untreated [37,38].
Ettinger et al., [39] in this study assessed the frequency of depressive 
symptoms, quality of life and disability among a community-based 
sample comprising epilepsy, asthma, and health control groups. His 
results indicated that from the population selected, 36.5% with epilepsy, 
27.8% with asthma, and 11.8% of health control group were positive 
on center for epidemiological studies-depression scale (p<0.001). 
These findings thus suggest that depression is much more prevalent in 
epileptic patients when seen in comparison to other groups.
Yousafzai et al., in this cross-sectional study on 100 patients in a clinical 
diagnostic center for epilepsy, diagnosed patients with depression 
using ICD-10 diagnostic criteria. 100 patients were included in the 
study. It showed that 60% of the population that were included showed 
symptoms of depression when the interview was conducted. Predictors 
of depression that have a significant association with depression were 
identified as male gender, married status, and low socioeconomic 
status [34]. Frequency was relatively seen to be high.
In an ongoing cross-sectional study in Campinas, a city to the south-east 
of Brazil, Sabrina et al. given a population of 171 individuals with 
epilepsy, estimated the periodicity of depression or anxiety in PWE. The 
prevalence of anxiety and depression was observed in 39.4% and 24.4%, 
respectively. Significant factors that were associated with depression 
and anxiety were low schooling (OR 3.8, 2.8), lifetime suicidal thoughts 
(OR 4.4, 3.6) and lifetime suicidal attempts (OR 9.3, 6.9) [40].
In a cross-sectional study conducted for a period over 9 months involving 
100 cases of primary epilepsy Wazir et al. determined the frequency of 
depression among subjects who presented only with primary epilepsy 
using beck depression inventory (BDI). 46 male (46%) patients and 
54 female (54%) patients were enrolled for the study. 62% of patients 
with primary epilepsy reported to have depression during their course 
of life [41]. This study is comparable to the study by Yousafzai et al. Who 
suggested that depression was found in 60% of the population under 
his study [34].
Ting Zhao et al. conducted a study on 140 outpatients attending an 
epilepsy center in Huashan Hospital for a period of about 6 months 
and the patients were asked to fill questionnaires which contained data 
in liaison with epilepsy. Depressive levels were rated using HAMD-17 
scale, and QOLIE-31 was used to appraise the quality of life in epileptic 
patients. He detailed out the type of seizure presented by each patient. 
About one-fourth of the population presented with depression. He 
also suggested that the strongest predictors of depression were the 
seizure types (odds ratio= 3.773, p=0.049, β=1.328). Weaker predictors 
included seizure worry scores (OR= 0.947, p=0.030, β=−0.54), social 
function scores (OR=0.947, p=0.000, β=−0.10), and complex partial 
seizure score (OR=0.112, p=0.002, β=−2.187) [23].
Onwuekwe et al. conducted a cross-sectional cohort study in a 
population of 83 epileptic patients to determine the periodicity and 
the method of depression that occurs in epileptic patients who were 
assessed using BECKs inventory for depression. Depression was 
found in 71 (85.5%) of the patients. Minimal depression was seen in 
57 (68.7%), mild in 10 (12%), and moderate in 4 (4.8%) patients. No 
cases of severe depression were observed. No other variables showed a 
significant relationship with degrees of depression and concluded that 
recurring rate of depression among epileptic patients was observed to 
be as high as 85.5% [42].
On concluding, depression is considered as a psychiatric comorbidity 
whose frequency tends to be high than any other comorbidity in the 
lives of people with epilepsy. The higher rates of depression and anxiety 
within the society have prioritized the need to comprehend and treat 
the mental disorders in those presenting with epilepsy [40].
SUICIDAL TENDENCY ASSOCIATED WITH EPILEPTIC PATIENTS
Suicide is believed to be the 13th leading cause of death when considered 
globally [43] and attempted suicides are one of the major causes that 
leads to injury [44]. Psychiatric disorders mainly the affective disorders 
can increase the risk of the patient to attempt suicide [45,46]. Epilepsy 
also increases the risk of attempting suicide among patients who 
undergo psychiatric illness [47] and concomitantly epilepsy can also 
jeopardize the life of the patient and exposes the patient to develop 
psychiatric illness [48].
Various studies which include people with epilepsy (PWE) have 
shown suicide as a main cause of death, and its prevalence rate is keep 
on elevating. Even though most of the studies have not reported an 
increased rate of danger due to suicide, some collective data have proofs 
of about 12% risk among people with epilepsy (PWE). The endangered 
population involves children’s, adolescents as well as adults. Elevated 
suicide attempts are reported in those subjects with epilepsy [49].
Chirstensen et al. conducted a population-based case–control study 
by identifying 21,169 cases of suicide and 423,128 controls. Within 
that population 492 (2.32%) individuals who committed suicide had 
epilepsy compared with 3140 (0.74%) controls. Patients with epilepsy 
were identified as the ones to have a high rate of suicidal tendency 
even though they were adjusted for socioeconomic factors (p<0.0001). 
Epileptic patients showed dangers of attempting suicide in their first 
half year of diagnosis (p<0.0001), and it was especially seen high 
in those patients with a history of the comorbid psychiatric disease 
(p<0.0001) [47].
Natasa et al. conducted a study in 50 patients who were selected 
randomly with epilepsy to analyze the presence of suicidal ideation in 
such patients. General questionnaire, HAM-D-17 (Hamilton 1960), The 
Beck Hopelessness Scale, and Beck Scale for Suicide Ideation were the 
instruments employed for the study. 38% of subjects presented with 
thoughts of death and suicide. Half of the participants showed feelings 
of hopelessness and symptoms that were similar to that depression. 
A significant relationship was believed to exist between suicidal 
ideation and the presence of chronic pain (p=0.49), sexual/physical 
abuse history (p=0.015), level of hopelessness (p=0.000), and severity 
of depression (p=0.000) in patients with epilepsy [50].
A meta-analytical study using randomized trials which revealed 
that AEDs have a potency to cause a hike in the incidence of suicidal 
thoughts and behavior. A nested case–control cohort studies in 44,300 
PWE who are under treatment with AEDs were studied to identify 
patients who have tendencies for suicide or cause self-harm. Andersohn 
et al. included 453 patients and 8,962 age and sex-matched controls. 
AEDs were categorized based on the potential to cause depression. His 
studies expedited that use of newer AED’s that shows a high potential 
of causing depression was even related with an increase in suicidal/ 
self-harm behavior. Conventional AED’s, low-risk new AED’s was found 
to have no association with suicidal tendencies [51].
Pompili et al. [52] in a meta-analytic study of 29 cohorts comprising 
50,814 patients, out of which 187 committed suicides indicated 
that suicidal behavior in epilepsy patients are more prevalent when 
compared to other population. The Index Medicus through Medline and 
World Health Statistics Annual was thoroughly assessed to determine 
the suicide rates prevailed among different age groups during the 
specific period of time and country.
All in all, we can conclude that epileptic patients are often encountered 
with higher rates of suicidal thoughts. Use of AEDs has also been 
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shown as a contributing factor toward suicidal behavior in epileptic 
patients. On the contrary, attempted suicides also have increased the 
risk of unprovoked seizures [53]. Thus, patients with epilepsy must be 
carefully evaluated for their behavior and other related risks.
TREATMENT OF DEPRESSION IN EPILEPTIC PATIENTS
When treating a patient who presents with the complaints of both 
epilepsy and depression, the aim should be focussed mainly on 
controlling the seizure and its frequency by the use of appropriate 
AED’s [9]. Adherences toward AEDs occupy an indispensable role 
in maintaining the control of seizures in those presenting with 
epilepsy [54]. Some anticonvulsants have shown to improve moods 
in epileptic patients which include drugs such as sodium valproate, 
carbamazepine, levetiracetam, lamotrigine, and gabapentin. These 
drugs also have shown their potential in preventing acute maniac and 
depressive episodes in patients with BD [9]. Thus, these drugs may be 
beneficial for epilepsy patients with depression.
Before initializing the therapy for depression in epileptic patients, all 
possible ways should be scrutinized to make sure that the depressive 
episodes are not the result of a sudden change in anti-epileptic regimen. 
Drug of choice for treating depression in epileptic patients is decided based 
on the prominent symptom of the depression exhibited by the subject [55].
Intra-nasal midazolam and intra-venous diazepam were given as a 
treatment option to pediatric population for prolonged febrile seizures. 
Eli et al. in her prospective randomized study on 47 children’s who 
are of age 6 months to 5 years with these drugs found that both the 
drugs showed equal efficacy but seizure control was found to be more 
fast with intravenous diazepam and the overall time for seizures for 
cessation was faster with intra-nasal midazolam. Hence, both were 
equally proven effective for controlling seizures [56].
Mary et al. in her double-blind study for determining the treatment 
options that are available for treating depression in those with epilepsy 
enrolled 42 patients who are epileptic and also undergone depressive 
episodes. An antidepressant trial of amitriptyline, nomifensine and 
placebo was initiated. 25 mg TID was the dose of the active drug, and it 
was doubled in non-responders after 6 weeks, serum antidepressants 
and anticonvulsant levels were assessed after 6 weeks follow-up. 
Results indicated that at the end of 6 weeks all patients showed a 
decline in their depression score and at the end of 12 weeks it was 
identified that nomifensine was superior to amitriptyline [57].
Devinsky et al. conducted a prospective multi-center study to 
understand the changes in depression and anxiety when the epileptic 
patient undergoes a respective surgery. Subjects were reviewed using 
Beck psychiatric symptoms scale (BDI, Beck Anxiety Inventory- BAI) 
and Composite International Psychiatric Interview-CIDI) for a period of 
24 months. A total of 358 pre-surgical BDI and 360 BAI was reviewed 
during the study. Depression and anxiety were prevailing among these 
patients and were observed as 22.1% and 24.7%, respectively. Post-
surgery rates of depression were found to be declined successively 
in the 3, 12, 24 months follow-up. At the end of 24 months follow-up, 
moderate to severe levels of depression and anxiety were found only 
in 17.6% and 14.7% of subjects who had episodes of seizure even after 
surgery and 8.2% in patients who were seizure free [58].
Studies have suggested that depressive episodes can be also related with 
AED. In a cohort study of 39 epileptic patients, David et al. indicated that 
depressive rates were seen high in patients treated with phenobarbital 
when they are compared to patients treated with carbamazepine or no 
anticonvulsants (38% vs. 0%, p=0.04) [59].
Santosh et al. in an experimental study on male Swiss albino mice 
using the methanolic extract of Passiflora foetida (MEPF) leaves, a 
traditional Mexican medicine, demonstrated that administration of 
different doses of MEPF was able to induce antidepressant effects 
in mice. Harmaline alkaloids present in MEPF acts as a reversible 
mono-amino oxidase inhibitor and thus causes a reduction in the 
metabolism of catecholamine’s and result in a subsequent increase in 
its concentrations. Flavonoid components also may bind to adrenergic 
and serotonergic systems and mediate antidepressant effect. Even 
though the exact mechanism is unknown traditional medicines have 
earned its place in substantial cure of depressive symptoms [60]. Thus, 
many plant extracts and phytoconstituents are investigated by the 
researchers for the treatment of epilepsy [61,62].
Table 1: Studies showing prevalence of psychological disorders in epilepsy
Country Author Number of 
Patients
Instrument Method Psychiatric 
disorder
Depression Anxiety Psychosis
Iran Asadi-Pooya and 
Sperling, 2006 [26]





- 9.5% 24.5% -




- 16.5% - -
USA Victoroff, 1994 [28] 60 SCID–P, 
DSM-III-R
- 70% 58.3% 31.7% 13.3%
Brazil de Araujo et al., 2007 [29] 106 DSM-IV Cross- sectional, 
population 
based study
61.3% 30% - Inter-ictal-14%. 
Post-ictal-9.4%
- Mensah et al., [30] 499 HADS Population 
based study
- 16.6%- borderline, 
11.2%- clinical
- -
Montengaro Vujisic et al. [31] 70 HAM-D, HAM-A - - 32.8% 21.4% -







- 45.2% - -





- 44% - -







- 32.8% 33.5% -
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Treatment for both epilepsy and depression should be carried out 
simultaneously to prevent further risks to the patients. Studies have 
shown that depression can develop as a result of therapy with AEDs. 
Hence, care-full evaluation of the drugs should also be carried out in 
order for a better outcome.
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